Human pegivirus‐1 infection in kidney transplant recipients: A single‐center experience
- 13 March 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (12) , 2961-2968
Abstract
Kidney transplantation is the treatment of choice for patients with end‐stage renal disease. In the posttransplant period, the induced immunosuppression leads to an increased risk of developing infectious diseases, a leading cause of death after kidney transplantation. Human pegivirus‐1 (HPgV‐1) is considered a nonpathogenic human virus and is highly frequent in individuals parenterally exposed, however, its impact on kidney transplantation outcome is poorly understood. Given the scarcity of epidemiological data for this infection on organ recipients in Brazil, we conducted a study in a single center for kidney transplantation in Rio de Janeiro, aiming to determine HPgV‐1 prevalence and genotypic distribution. Serum samples from 61 renal recipients, followed up for the first year after transplantation, were evaluated for viral RNA and genotypes were determined by sequencing of the 5′‐untranslated region. HPgV‐1 RNA was detected in 36.1% (22/61) of patients. Genotype 2 was the most commonly found (80.9%), followed by genotypes 3 (9.5%), 1, and 5, in 4.8% each. Statistical comparisons did not reveal any significant impact of HPgV‐1 in patient outcome. Further epidemiologic studies are needed to understand if immunosuppression may interfere in HPgV‐1 persistence rates and if viremia might impact graft dysfunction rates in kidney recipients.Keywords
Funding Information
- Fundação Oswaldo Cruz
This publication has 30 references indexed in Scilit:
- Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infectionJournal of General Virology, 2015
- GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individualsAIDS, 2013
- A Novel Genotype of GB Virus C: Its Identification and Predominance among Injecting Drug Users in Yunnan, ChinaPLOS ONE, 2011
- Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, BrazilPLOS ONE, 2011
- Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapyVirus Research, 2010
- Estudo epidemiológico da doença renal crônica terminal no oeste do Paraná: uma experiência de 878 casos atendidos em 25 anosBrazilian Journal of Nephrology, 2010
- High prevalence of GB Virus C/Hepatitis G Virus RNA among Brazilian blood donorsRevista do Instituto de Medicina Tropical de São Paulo, 2003
- GB virus C/hepatitis G virus infection among renal transplant recipients in İzmir, Turkey: Molecular analysis of phylogenetic groupsInternational Journal of Infectious Diseases, 2002
- High prevalence, low pathogenicity in hepatitis G virus in kidney transplant recipientsDigestive and Liver Disease, 2001
- Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus‐infected bloodTransfusion, 1999